Dec. 2, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, will present 14 studies at RSNA 2025. Spanning screening mammography, digital breast tomosynthesis (DBT), breast density science and risk modeling, this year’s program represents one of the company’s most extensive evidence portfolios to date. Lunit will exhibit at South Hall, Booth #4100, and host expert-led sessions in the Lunit Education Room #1252.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now